Concepedia

Publication | Open Access

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer

35

Citations

28

References

2020

Year

Abstract

The combination of guadecitabine and cisplatin was tolerable and demonstrated activity in patients with platinum refractory germ cell cancer.

References

YearCitations

Page 1